1. Madsen JM. Toxins as weapons of mass destruction. Clinics in Laboratory Medicine, 2001, 21:593 - 605.
2. Roberts B, Moodie M. Biological weapons: towards a threat reduction strategy. Washington, DC, National Defense University, 2002 (Defense Horizons, No. 15).
3. United States of America. Working paper on toxins. Conference of the Committee on Disarmament, 21 April 1970 (document CCD/286).
4. United States Code; Title 18, Crimes and Criminal Procedure; Chapter 10, Biological Weapons; Section 178, Definitions.
5. Final document: 2nd Review Conference of the Parties to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons. Geneva, United Nations, 1986 (document BWC/CONF.II/13).
6. Koch BL, Edvinsson AA, Koskinen LO. Inhalation of substance P and thiorphan: acute toxicity and effects on respiration in conscious guinea pigs. Journal of Applied Toxicology, 1999, 19:19 - 23.
7. Novel toxins and bioregulators. Ottawa, Ministry of External Affairs and International Trade, 1991.
8. Evaluation of biological agentes and toxins: working paper submitted by the Republic of Croatia. Geneva Ad Hoc Working Group of the States Parties to the Convention on the Prohibition of the Development, Production and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on their Destruction. Geneva, United Nations, 19 July 1999 (document BWC/ADHOCGROUP/WP.356/Rev.1).
9. Bokan S, Breen SG, Orehovec Z. An evaluation of bioregulators as terrorism and warfare agentes. ASA Newsletter, 2002, 90:16 - 19.
10. Dando M. The new biological weapons: threat, proliferation, and control. Boulder, CO, Lynne Rienner, 2001:67 - 85.
11. Kagan E. Bioregulators as instruments of terror. Clinics in Laboratory Medicine, 2001, 21:607 - 618.
12. Sidell FR, Takafuji ET, Franz DR, eds. Medical aspects of chemical and biological warfare. Washington, DC, Department of the Army, Office of The Surgeon General and Borden Institute, 1997.
13. Handbook: medical management of biological casualties, 2nd ed. Fort Detrick, MD, United States Army Medical Research Institute of Infectious Diseases, 1996.
14. Patocka J, Splino M. Botulinum toxin: from poison to medicinal agent. ASA Newsletter, 2002, 88:14 - 19.
15. Shapiro RL, Hatheway C, Swerdlow DL. Botulism in the United States: a clinical and epidemiological review. Annals of Internal Medicine, 1998, 129:221 - 228.
16. Arnon SS et al. Botulinum toxin as a biological weapon: medical and public health management. Journal of the American Medical Association, 2001, 285:1059 - 1070.
17. Franz DR et al. Efficacy of prophylactic and therapeutic administration of antitoxin for inhalation botulism. En: Dasgupta BR, ed. Botulinum and tetanus neurotoxins: neurotransmission and biomedical aspects. New York, Plenum, 1993:473 - 476.
18. Malloy CD, Marr JS. Mycotoxins and public health: a review. Journal of Public Health Management and Practice, 1997, 3:61 - 69.
19. Compilation of declarations of information by BWC States Parties in accordance with the extended confidence-building measures agreed at the Third Review Conference. New York, United Nations, Office of Disarmament Affairs, 1992 (document DDA/4-92/BW3, Add.1, Add.2, and Add.3: Form F filed by the Russian Federation, as translated by WHO).
20. Report: disarmament (as transmitted to the President of the Security Council, 27 January 1999, and subsequently distributed as document S/1999/94, dated 29 January 1999). New York, United Nations, 1999.
21. Tucker JB. The «Yellow Rain» controversy: lessons for arms control compliance. The Nonproliferation Review, 2001, 8:25 - 42.
22. Some naturally occurring substances: food items and constituents, heterocyclic aromatic amines and mycotoxins. Lyon, International Agency for Research on Cancer, 1993:245 - 384 (IARC Monographs on the evaluation of carcinogenic risks to humans, Vol. 56).
23. Eaton DL, Groopman JD, eds. The toxicology of aflatoxins. Human health, veterinary and agricultural significance. London, Academic Press, 1994.
24. Rotter BA, Prelusky DB, Pestka JJ. Toxicology of deoxynivalenol (vomitoxin). Journal of Toxicology and Environmental Health, 1996, 48:1 - 34.
25. Evaluation of certain mycotoxins in food. Fifty-sixth report of the Joint FAO/WHO Expert Committee on Food Additives. Geneva, World Health Organization, 2002 (WHO Technical Report Series, No. 906).
26. United States National Library of Medicine. Hazardous Substances Data Bank, 1999 (diponible en http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB).
27. Aune T. Health effects associated with algal toxins from seafood. Archives of Toxicology Supplement, 1997, 19:389 - 397.
28. Schantz EJ. Biochemical studies on paralytic shellfish poison. Annals of the New York Academy of Sciences, 1960, 90:843 - 855.
29. Griffiths GD et al. Protection against inhalation toxicity of ricin and abrin by immunisation. Human and Experimental Toxicology, 1995, 14:155 - 164.
30. Cope AC, Dee D, Cannan RK. Ricin. En: Renshaw B, ed. Summary Technical Report of Division 9, NDRC. Vol. 1: Chemical warfare agentes and related chemical problems, parts I - II. Washington, DC, National Defense Research Committee, 1946:179 - 203.